KidneyCure Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $4M
Latest Deal Amount
  • Investors
  • 5

KidneyCure General Information

Description

Developer of cell-based personalized drugs designed to compensate for renal cell depletion by administrating autologous, revitalized renal progenitor cells. The company's drugs are expected to significantly improve kidney function, prevent the formation of fibrotic renal tissue and delay the progression of the disease, enabling patients suffering from renal diseases to expect a substantial delay in the need for dialysis and kidney transplantation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 9 Ahad Ha'am
  • P.O.B 29866
  • Tel Aviv 6129801
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KidneyCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC (Series A) 18-Nov-2018 $4M 000 Completed Generating Revenue
To view KidneyCure’s complete valuation and funding history, request access »

KidneyCure Executive Team (3)

Name Title Board Seat Contact Info
Alon Yaar Chief Executive Officer & Board Member
Benjamin Dekel MD Co-Founder & Chief Scientific and Medical Advisor & Board Member
To view KidneyCure’s complete executive team members history, request access »

KidneyCure Board Members (4)

Name Representing Role Since
Alon Yaar KidneyCure Chief Executive Officer & Board Member 000 0000
Jonathan Leitersdorf KidneyCure Board Member 000 0000
Oded Ben-Joseph Ph.D Self Board Member 000 0000
Ran Avnat KidneyCure Board Member 000 0000
To view KidneyCure’s complete board members history, request access »

KidneyCure Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aurum Ventures MKI Venture Capital Minority 000 0000 000000 0
Gilad Altshuler Angel (individual) Minority 000 0000 000000 0
IDI Direct Insurance Corporation Minority 000 0000 000000 0
John Finberg Angel (individual) Minority 000 0000 000000 0
Jonathan Leitersdorf Angel (individual) Minority 000 0000 000000 0
To view KidneyCure’s complete investors history, request access »

KidneyCure Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000 00 000 01-Apr-2020 00000 0000000 Other Commercial Products
To view KidneyCure’s complete investments history, request access »